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Objective: The level of hippocampal atrophy in dementia with Lewy bodies (DLB) is typically less than
that observed in Alzheimer’s disease (AD). However, it is not known how the cognitive phenotype of
DLB is inﬂuenced by hippocampal atrophy or the atrophy of adjacent medial temporal lobe structures.
Methods: Dementia with Lewy bodies (n = 65), AD (n = 76) and control (n = 63) participants
underwent 3T magnetic resonance imaging and cognitive Cambridge Cognitive Examination and
Mini-Mental State Examination (CAMCOG and MMSE) assessments. Hippocampal volume, and
parahippocampal, entorhinal and temporal pole cortical thickness, was compared between groups.
Regression models were used to investigate whether hippocampal volume and cortical thickness
associated with global cognition and cognitive subdomains.
Results: Dementia with Lewy bodies, AD and control participants showed signiﬁcantly different
hippocampal, parahippocampal and entorhinal cortical thinning, where atrophy was greatest in AD
and intermediate in DLB. Temporal pole thickness was reduced in DLB and AD compared with control
participants. In DLB, but not AD, hippocampal volume associated with total CAMCOG, CAMCOG
memory and MMSE scores. In DLB, parahippocampal, entorhinal and temporal pole thickness
associated with total CAMCOG and CAMCOG memory scores, parahippocampal thickness associated
with MMSE scores, and entorhinal thickness associated with CAMCOG executive function scores.
Conclusions: In this large sample, these results are in agreement with other studies indicating that
hippocampal atrophy is less severe in DLB than AD.Hippocampal atrophy andmedial temporal lobe cortical
thickness were associated with the severity of cognitive symptoms, suggesting that atrophy in these structures,
as a potential proxy of AD pathology, may partly mediate speciﬁc DLB cognitive symptoms.# 2017 The
Authors. International Journal of Geriatric Psychiatry Published by John Wiley & Sons Ltd.
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Introduction
Dementia with Lewy bodies (DLB) is the second most
common cause of dementia in older people after
Alzheimer’s disease (AD), and accounts for 15–20%
of all dementia cases at post mortem (McKeith et al.,
2005). DLB is characterised by symptoms including
motor and neuropsychiatric problems, executive
dysfunction and visuospatial deﬁcits, visual
hallucinations, autonomic dysfunction and marked
ﬂuctuations in alertness (McKeith et al., 2005;
McKeith, 2006). There are differences between the
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symptom proﬁle of DLB and AD, where memory
problems are typically more pronounced in AD, and
attentional and visuoperceptual difﬁculties are more
prominent in DLB (Calderon et al., 2001; Ferman
et al., 2006).
To date, the use of magnetic resonance (MR)
imaging has been useful in understanding the
differences between DLB and AD, despite the low-to-
intermediate co-existence of AD neuropathology in
individuals with DLB (Merdes et al., 2003; McKeith
et al., 2005; Schneider et al., 2012). One particular
region of relevance is the hippocampus, which is
located within the medial temporal lobe and has a
functional role in declarative memory, emotional
memory and spatial navigation (Eichenbaum, 2004;
Strange et al., 2014). Hippocampal atrophy is a marker
of AD pathology, as hippocampal volume has been
shown to negatively associate with the tau and amyloid
beta burden in AD (Apostolova et al., 2015) and
hippocampal atrophy can predate a diagnosis of
dementia by a period of up to several years (Tondelli
et al., 2012; de Flores et al., 2015) also making it a
potentially important prodromal biomarker.
Hippocampal AD pathology is also a feature of
DLB, as previous imaging studies have consistently
demonstrated that the level of hippocampal atrophy
observed in DLB is less than in AD (Hashimoto
et al., 1998; Tam et al., 2005; Burton et al., 2009;
Watson et al., 2012), and the level of atrophy relates
to concurrent AD pathology measured post mortem
(Burton et al., 2009; Kantarci et al., 2012). The extent
of the atrophy may also inﬂuence the subsequent
clinical course of DLB, as individuals with higher
levels of hippocampal atrophy have a shorter survival
time compared with those with lower levels of atrophy
(Graff-Radford et al., 2016).
It is not known how hippocampal atrophy, or the
thickness of adjacent medial temporal lobe structures,
inﬂuences the cognitive phenotype of DLB. Three
relevant subregions are (i) the parahippocampal gyrus,
which has a predominant role in episodic memory and
an involvement in visuospatial processing (Aminoff
et al., 2013); (ii) the entorhinal cortex, which relays
information from sensory cortical areas of the
hippocampus, and from the hippocampus to
neocortical storage areas (Heinemann et al., 2000);
and (iii) the temporal pole, which has a role in
cognition and memory function and particularly
declarative memory (Blaizot et al., 2010). Whilst one
previous study showed that compared with healthy
control participants, DLB participants showed
reductions in the thickness of the right entorhinal,
right perirhinal and right parahippocampal areas;
there were no differences compared with AD
participants and no associations between these regions
and cognitive variables in DLB (Delli Pizzi et al.,
2016). However, the main limitation of this study
was in the relatively modest sample size.
Therefore, the main aim of the present study was to
investigate whether hippocampal atrophy, as a proxy
of AD pathology, is associated with cognitive deﬁcits
in DLB, in a large sample of dementia patients. A
secondary aim was to examine the association between
the thickness of the parahippocampal gyrus,
entorhinal cortex and temporal pole, and measures
of cognition in DLB. It was hypothesised that DLB
patients would display a level of hippocampal atrophy
that was greater in severity than healthy control
individuals but less than that observed in AD, and
individuals with DLB would display a greater level of
surface atrophy in adjacent medial temporal lobe
subregions, as compared with healthy controls, but
less than that observed in AD.
Method
Participants
A total of 204 participants (Mage = 77.75 years;
SDage = 6.76 years), including 76 with probable AD
(McKhann et al., 1984), 65 with probable DLB
(McKeith et al., 2005) and 63 similarly older healthy
controls, were recruited from a community-dwelling
population of patients referred to Old Age Psychiatry,
Geriatric Medicine or Neurology services. Control
participants were recruited from the relatives and
friends of patients with dementia and from a bank of
volunteer participants held by Newcastle University.
Exclusion criteria for all participants included
contra-indications for MR imaging, a previous history
of alcohol or substance misuse, a signiﬁcant
neurological history or psychiatric illness, focal brain
lesions, or the presence of other relevant severe or
uncontrolled illnesses. Participants, or their nearest
relative or carer, provided informed consent. The
diagnosis of DLB was conﬁrmed by two senior
experienced clinicians. The study was approved by
the local research ethics committee.
Measures
Global cognition was assessed using the Mini Mental
State Examination (MMSE; Folstein et al., 1975) and
the Cambridge Cognitive Examination (CAMCOG;
Roth et al., 1986). In DLB and AD patients, the
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severity of parkinsonian motor symptoms were
assessed using Part III of the Uniﬁed Parkinson’s
Disease Rating Scale (UPDRS-III; Goetz et al., 2008),
and with the help of a carer/informant, the severity
of visual hallucinations and depressive symptoms in
the previous four weeks were assessed using the
Neuropsychiatric Inventory (NPI; Cummings et al.,
1994), and the severity of cognitive ﬂuctuations in
the previous four weeks were assessed using the
Clinician Assessment of Fluctuation Scale (Walker
et al., 2000).
Magnetic resonance imaging data acquisition
All participants underwent MR imaging within
2 months of completing neuropsychiatric assessments.
T1-weighted whole brain scans were obtained using a
3T Intera Achieva scanner (Philips Medical Systems,
Eindhoven, Netherlands) with an eight-channel head
coil. The imaging sequence protocol was as follows:
3D MPRAGE, sagittal acquisition, 1-mm isotropic
resolution, matrix size of 240 (anterior–
posterior) × 216 (superior–inferior) × 180 (right–left);
repetition time = 8.3 ms, echo time = 4.6 ms; SENSE
factor = 2; ﬂip angle = 8°. The acquired volume was
angulated such that the axial slice orientation was
standardised to align with the AC–PC line.
Calculation of hippocampal and total grey matter
volumes and cortical thickness
Estimates of hippocampal and total grey matter (GM)
volumes as well as regional cortical thickness of
speciﬁc medial temporal lobe structures
(parahippocampal gyrus, entorhinal cortex and
temporal pole) were obtained for each participant
using FREESURFER (v.5.1.0, http://surfer.nmr.mgh.
harvard.edu/). The technical aspects of these methods
have been described elsewhere (Dale et al., 1999; Fischl
et al., 1999; Fischl and Dale, 2000). In brief, the
processing stream involves intensity non-uniformity
correction, Talairach registration, the removal of
non-brain tissue (skull stripping), segmentation of
white matter (WM) and subcortical GM structures
(Fischl et al., 2002), tessellation of the GM-WM
boundary then surface deformation following GM-
cerebrospinal ﬂuid (CSF) intensity gradients to
optimally place GM-WM and GM-CSF borders (Dale
et al., 1999; Fischl and Dale, 2000). Once cortical
models were generated, surface inﬂation,
transformation to a spherical atlas and parcellation
of the cerebral cortex into regions based on gyral and
sulcal structure were undertaken (Makris et al.,
2006). This technique used both intensity and
continuity information from the entire 3D MR
volume in the segmentation and deformation
procedures to produce representations of cortical
thickness, calculated as the closest distance from the
GM-WM to GM-CSF boundaries at each vertex on
the tessellated surface (Fischl et al., 2004). Total GM
volume was calculated as the sum of subcortical,
cortical (left and right) and cerebellum GM.
Visual inspection of images at each step of the
FREESURFER processing stream was carefully conducted
by a single operator (S. J. C.) to ensure segmentation
accuracy of the subcortical structures, as well as
WM/pial surfaces and tissue classiﬁcations. Images
with segmentation errors, which were unable to be
corrected, were excluded from subsequent analyses.
Data analysis
Cambridge Cognitive Examination total, memory and
executive function, MMSE, UPDRS-III, NPI
depression, NPI visual hallucinations and Clinician
Assessment of Fluctuation Scale scores were compared
between DLB, AD and control participants using a
one-way analysis of variance or independent-samples
t-tests, where appropriate. Chi-squared tests were used
to assess group differences in age and gender. The
volume of the left, right and total hippocampus
(mm3) were compared between-groups using an
analysis of covariance, controlling for intracranial
volume. Left, right and total cortical thickness
measures of the parahippocampal gyrus, entorhinal
cortex and temporal pole (mm) were compared
between DLB, AD and control groups using a series
of one-way analysis of variances. Post-hoc comparisons
were Bonferroni-corrected (p = .017), where
appropriate.
Separate linear regression models were used, with
the inclusion of age and intracranial volume as
covariates, to investigate whether total hippocampal
volume was associated with cognitive scores
(CAMCOG total, CAMCOG memory, CAMCOG
executive function and MMSE). In addition, linear
regression models, with the inclusion of age as a
covariate, examined whether total cortical thickness
measures of the parahippocampal gyrus, entorhinal
and temporal poles were associated with cognitive
scores. Additional exploratory analyses were also
conducted using linear regression models, with the
inclusion of age as a covariate, to examine whether
total parahippocampal, entorhinal and temporal pole
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cortical thickness was associated with other CAMCOG
subscales (orientation, language, attention,
calculation, praxis, abstract thinking and perception),
and with three further memory subdomains (remote
memory, recent memory and learning memory).
Results
Demographic and clinical results
Demographic and clinical results are shown in Table 1.
DLB, AD and control groups did not differ in age or
gender (p > .05). There were signiﬁcant between-
group differences in CAMCOG total scores
(F(2,203) = 132.18, p < .001, η2p = .57), CAMCOG
memory (F(2,203) = 182.57, p < .001, η2p = .65) and
CAMCOG executive function subscores
(F(2,203) = 108.78, p < .001, η2p = .52). Compared
with control participants, CAMCOG scores were
signiﬁcantly lower in DLB and AD, but there were
no differences between the dementia groups. All three
groups showed signiﬁcant differences on CAMCOG
memory scores, where control participants showed
the lowest levels of impairment, DLB participants
intermediate impairment and AD the greatest levels
of impairment. For CAMCOG executive function
scores, post-hoc comparisons showed that DLB
participants had lowest scores, AD participants
displayed intermediate scores and controls had the
highest scores. MMSE scores were signiﬁcantly
different between DLB, AD and control groups
(F(2,203) = 101.97, p < .001, η2p = .50). Post-hoc
comparisons indicated that control participants
obtained highest scores but that there were no
differences between DLB and AD groups.
As expected, there were signiﬁcant differences
between all three groups in terms of UPDRS-III scores
(F(2,199) = 48.73, p < .001, η2p = .33), where motor
impairments were greater in DLB compared with AD
and control participants. Similarly, cognitive
ﬂuctuations were more severe in DLB than in AD
participants (t(100.71) = 5.30, p < .001). DLB
participants also had signiﬁcantly more visual
hallucinations in the previous month compared with
AD participants (t(59.70) = 5.66, p < .001) but not
depressive symptoms (t(111) = .55, p > .05).
Neuropsychiatric symptoms were not associated with
hippocampal volume (all p-values > .05).
Magnetic resonance imaging
There were signiﬁcant differences in intracranial
volume between DLB, AD and control groups
(F(2,204) = 4.46, p < .05, η2p = .04), where DLB
participants had a signiﬁcantly greater volume than
control but not AD participants. Signiﬁcant
differences were observed in the left hippocampus
(F(2,203) = 67.12, p < .001, η2p = .40), right
hippocampus (F(2,203) = 52.95, p < .001, η2p = .35)
and in total hippocampal volumes (F(2,203) = 65.53,
Table 1 Demographic and group characteristics
DLB (n = 65) AD (n = 76) Control (n = 63)
Group
comparisonsMean SD Mean SD Mean SD
Age 78.40 6.47 77.99 7.51 76.81 6.05 p > .05
Disease duration (months) 35.96 27.74 32.61 21.83 N/A N/A p > .05
Gender (male/female) 45/20 48/28 36/27 p > .05
CAMCOG total 67.94 15.27 67.09 12.96 96.76 3.77 p < .001a,b
CAMCOG memory score 15.40 4.99 10.42 4.45 23.52 1.79 p < .001a,b,c
CAMCOG executive function 11.66 5.15 13.67 4.64 22.36 2.95* p < .001a,b,d
MMSE 20.46 5.23 20.25 4.32 29.00 1.00* p < .001a,b
UPDRS-III total 20.51 13.14 3.79 3.68 6.19 12.81* p < .001
CAF 5.47 4.03 1.85 3.40 N/A N/A* p < .001
NPI hallucinations 2.30 2.55 .25 .81 N/A N/A* p < .001
NPI depression 1.17 2.42 .97 1.57 N/A N/A p > .05
AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; CAMCOG, Cambridge Cognitive Examination; CAF, Clinician Assessment of
Fluctuation Scale; MMSE, Mini-Mental State Examination; NPI, Neuropsychiatric Inventory; SD, standard deviation; UPDRS-III, Uniﬁed
Parkinson’s Disease Rating Scale (Part III).
aDLB < control.
bAD < control.
cAD < DLB.
dDLB < AD.
*p < .001.
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p < .001, η2p = .40). Post-hoc comparisons indicated
that hippocampal volume was lowest in individuals
with AD, moderate in individuals with DLB and
greatest in control participants (p < .001; Table 2).
Signiﬁcant differences in cortical thickness were
observed between DLB, AD and control groups in the
parahippocampal gyrus, left (F(2,203) = 20.03,
p < .001, η2p = .17), right (F(2,203) = 20.13, p < .001,
η2p = .17) and total thickness (F(2,203) = 23.88,
p < .001, η2p = .19); in entorhinal areas, left
(F(2,203) = 42.96, p < .001, η2p = .30), right
(F(2,203) = 28.22, p < .001, η2p = .22) and total
thickness (F(2,203) = 40.30, p < .001, η2p = .29); and
temporal pole, left (F(2,203) = 8.44, p < .001,
η2p = .08), right (F(2,203) = 12.67, p < .001, η2p = .11)
and total thickness (F(2,203) = 13.73, p < .001,
η2p = .12). Post-hoc comparisons indicated a consistent
difference in proﬁle (controls > DLB > AD) with the
exception of the temporal pole, where DLB and AD
participants both signiﬁcantly differed from controls
but not from each other (Table 3).
In DLB participants, total hippocampal volume was
signiﬁcantly associated with total CAMCOG (R2 = .21,
F(3,64) = 5.24, p< .01), CAMCOGmemory (R2 = .38,
F(3,64) = 12.25, p < .001), CAMCOG executive
function (R2 = .13, F(3,64) = 3.07, p< .05) and MMSE
scores (R2 = .13, F(3,64) = 2.95, p < .05; Table 4). In
AD, total hippocampal volume was not associated with
total CAMCOG, CAMCOG memory, CAMCOG
executive function, orMMSE scores (all p-values> .05;
Table S1).
In DLB, total parahippocampal thickness was
associated with total CAMCOG (R2 = .15,
F(2,64) = 5.64, p < .01), CAMCOG memory
(R2 = .21, F(2,64) = 8.05, p < .01) and MMSE
(R2 = .12, F(2,64) = 4.30, p < .05), but not CAMCOG
executive function scores (p > .05). Total entorhinal
thickness in DLB was associated with total CAMCOG
(R2 = .22, F(2,64) = 8.77, p< .001), CAMCOGmemory
(R2 = .41, F(2,64) = 21.36, p < .001), CAMCOG
executive function (R2 = .11, F(2,64) = 3.93, p < .05)
but not MMSE scores (p > .05). Total temporal pole
thickness in the DLB group was associated with total
CAMCOG (R2 = .16, F(2,64) = 5.71, p < .01),
CAMCOG memory (R2 = .26, F(2,64) = 10.79,
p < .001), but not CAMCOG executive function or
MMSE scores (p-values > .05; Table 5). In AD,
parahippocampal, entorhinal and temporal pole
thickness was not associated with total CAMCOG,
CAMCOG memory, CAMCOG executive function or
MMSE scores (all p-values > .05; Table S2).
Examination of CAMCOG subscales indicated that
in DLB participants, total parahippocampal thickness
was associated with language expression, attention,
calculation and all three memory subdomains
(remote, recent and learning memory); entorhinal
thickness was associated with orientation, language
expression, and all three memory domains, and
temporal pole thickness was associated with language
expression, calculation and the recent memory and
learning memory subdomains (model p-values < .05).
Discussion
The results of the present study indicate that
hippocampal atrophy, as a proxy of AD pathology, is
present in DLB but is less severe than in AD. DLB,
Table 2 Comparison of hippocampal volume between DLB, AD and control groups
DLB (n = 65) AD (n = 76) Control (n = 63)
Group
comparisonsMean SD Mean SD Mean SD
Left Hippocampus
volume (mm3) 3062.00 596.26 2536.38 626.28 3564.75 469.21 p < .001a,b,c
Right Hippocampus
volume (mm3) 3121.40 580.33 2598.74 626.26 3539.70 558.45 p < .001a,b,c
Total Hippocampus
volume (mm3) 6183.40 1134.45 5135.12 1199.19 7104.44 981.17 p < .001a,b,c
Total Intracranial
Volume (mm3) 1318687.47 261299.23 1288641.50 247635.81 1198843.29 192283.20 p < .05a
AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; SD, standard deviation.
aDLB < control.
bAD < control.
cAD < DLB.
*p < .05.
**p < .01.
***p < .001.
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AD and control groups showed signiﬁcant differences
in left, right and total parahippocampal, entorhinal
and temporal pole surface thickness, where the
thickness was greatest in controls, intermediate in
DLB and lowest in AD. One exception to this was in
the left temporal pole, where the surface thickness
was greatest in controls but did not differ between
DLB and AD groups. These results also indicated that
hippocampal atrophy was associated with the severity
of speciﬁc cognitive deﬁcits in DLB, as total
hippocampal volume was associated with total
CAMCOG and MMSE scores, as global measures of
cognition and with CAMCOG memory subscores. In
DLB, parahippocampal surface thickness was
associated with total CAMCOG, CAMCOG memory
and MMSE scores; entorhinal surface thickness was
associated with CAMCOG total, CAMCOG memory
and executive function scores and temporal pole
surface thickness was associated with CAMCOG total
and CAMCOG memory scores. In AD,
parahippocampal, entorhinal and temporal pole
thickness was not associated with measures of
cognition.
These results are in agreement with previous
studies, which have observed that the hippocampus
is relatively preserved in DLB as compared with AD
(Hashimoto et al., 1998; Tam et al., 2005; Burton
et al., 2009; Watson et al., 2012). The present study
also indicates that other regions of the medial
temporal lobe display an intermediate level of atrophy
in DLB, speciﬁcally in the parahippocampal,
entorhinal and temporal pole areas. With the
exception of the left temporal lobe area, DLB and
AD groups showed differential patterns of surface
Table 3 Comparison of medial temporal subregions between DLB, AD and control groups
DLB (n = 65) AD (n = 76) Control (n = 63)
Group
comparisonsMean SD Mean SD Mean SD
Left parahippocampal thickness (mm) 2.30 .35 2.12 .28 2.46 .32 p < .001a,b,c
Right parahippocampal thickness (mm) 2.28 .30 2.15 .31 2.47 .28 p < .001a,b,c
Left entorhinal thickness (mm) 2.79 .42 2.41 .42 3.01 .32 p < .001a,b,c
Right entorhinal thickness (mm) 2.79 .47 2.47 .51 3.06 .39 p < .001a,b,c
Left temporal pole thickness (mm) 3.32 .38 3.23 .49 3.51 .33 p < .001a,b
Right temporal pole thickness (mm) 3.28 .42 3.14 .56 3.55 .41 p < .001a,b
Total parahippocampal thickness (mm) 4.58 .60 4.27 .55 4.93 .54 p < .001a,b,c
Total entorhinal thickness (mm) 5.58 .82 4.88 .86 6.07 .66 p < .001a,b,c
Total temporal pole thickness (mm) 6.60 .72 6.37 .94 7.06 .61 p < .001a,b
aDLB < control;
bAD < control;
cAD < DLB.
*p < .05.
**p < .01.
***p < .001.
Table 4 Associations between total hippocampal volume and cognition
in DLB (n = 65)
B SE B β
CAMCOG total .01 .00 .47**
CAMCOG memory .00 .00 .68***
CAMCOG executive function .00 .00 .36
MMSE .00 .00 .37**
CAMCOG: Cambridge Cognitive Examination, MMSE: Mini-
Mental State Examination
*p < .05,
**p < .01,
***p < .001.
Table 5 Associations between medial temporal subregion cortical
thickness and cognition in DLB (n = 65)
B SE B β
Total parahippocampal thickness 9.54 3.02 .38**
CAMCOG total 3.15 .96 .38**
CAMCOG memory 1.72 1.08 .20
CAMCOG executive function 3.09 1.05 .36**
MMSE
Total entorhinal thickness 8.93 2.22 .48***
CAMCOG total 3.78 .63 .63***
CAMCOG memory 2.22 .80 .36**
CAMCOG executive function 2.04 .82 .32
MMSE
Total temporal pole thickness 8.14 2.56 .39**
CAMCOG total 3.13 .78 .46***
CAMCOG memory 1.45 .91 .20
CAMCOG executive function 1.75 .93 .24
MMSE 9.54 3.02 .38**
CAMCOG, Cambridge Cognitive Examination; DLB, dementia
with Lewy bodies; MMSE, Mini-Mental State Examination.
*p < .05.
**p < .01.
***p < .001.
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atrophy. These results are partially in agreement with a
previous study that demonstrated that compared with
controls, right entorhinal and parahippocampal
thickness was reduced (Delli Pizzi et al., 2016).
However, this previous study may have been
underpowered and thus unable to detect subtle
differences between DLB and AD. In the current
study, no relationship was observed between surface
thickness and cognitive measures in AD. Whilst
relationships between cognition and medial temporal
atrophy, and hippocampal volume, have been
observed in previous studies in individuals with mild
AD (Dickerson et al., 2009; Arlt et al., 2013), the lack
of a relationship in the present study may reﬂect
differences in AD participants, compared with the
present sample, and in the differing
neuropsychological measures used in these studies.
Overall, these results indicate that despite the
relative preservation of the hippocampus in DLB,
hippocampal atrophy is associated with global
cognitive and memory impairment, and these
relationships may represent AD pathology in the
hippocampus. However, other pathologies may
contribute to the cognitive symptoms of DLB and
should be investigated further; one study has previously
observed that cognitive decline in LBD may be a
consequence of alpha-synuclein, amyloid-beta and
phosphorylated tau pathology (Howlett et al., 2015),
and additionally, one study of the medial temporal lobe
showed that alpha-synuclein pathology, rather than AD
pathology, had a role in the atrophy of the amygdala
(Burton et al., 2012). Hippocampal volume showed
the strongest association with the CAMCOG memory
score, which is in keeping with the memory function
of the hippocampus (Eichenbaum, 2004; Strange
et al., 2014). These results also indicate that atrophy
to adjacent medial temporal lobe subregions can also
inﬂuence the DLB cognitive phenotype, with an
overlap of symptoms: parahippocampal surface
thickness was associated with CAMCOG cognition
and memory subscores, but not executive function,
the entorhinal surface thickness was associated with
total CAMCOG scores, as well as CAMCOG memory
and executive function subscores. No association was
observed between the MMSE, as a measure of global
cognition, and entorhinal thickness. Although AD
pathology typically ﬁrst appears in entorhinal regions
(Schonheit et al., 2004) and the entorhinal cortex
projects to the hippocampus, it is likely that the MMSE
is less sensitive to changes in entorhinal surface
thickness in DLB, given the large sample size of DLB
patients in the present study. In DLB, temporal pole
surface thickness was associated with total CAMCOG
and CAMCOG memory scores, most likely
representing the primary memory role of this
subregion (Blaizot et al., 2010). The lack of association
between hippocampal atrophy and common
neuropsychiatric symptoms in DLB, speciﬁcally
depressive symptoms and hallucinations, as well as
cognitive ﬂuctuations, reinforce arguments that these
are likely to be driven by pathologies in other regions.
It is a speciﬁc strength of the study that a relatively
large AD and DLB cohort was included, and that
imaging data was acquired using a 3T scanner as
compared with the lower ﬁeld strength of previous
studies (Tam et al., 2005; Burton et al., 2009), and that
a standardised image analysis tool was used to avoid
the limitations of manually delineating the
hippocampus. The main limitation of the study is in
the lack of concurrent amyloid biomarker imaging as
a measure of AD pathology. A further limitation is
the lack of longitudinal follow-up data; longitudinal
data is necessary to clarify whether hippocampal
atrophy, and the atrophy of adjacent medial temporal
regions, can predict the course of DLB.
Overall, despite similar levels of cognitive
impairment in DLB and AD, less hippocampal
atrophy was observed in DLB than AD. These results
suggest that amnestic deﬁcits in DLB may be, in part,
mediated by concurrent AD pathology in the
hippocampus and in the adjacent subregions of the
medial temporal lobe and may have clinical
implications in the stratiﬁcation of DLB patients, in
the future, for anti-amyloid disease-modifying
treatments. Indirectly, these data suggest a role for
non-AD pathology or AD related pathology, focused
in non-medial temporal lobe regions in the aetiology
of other cognitive domains in DLB; further work
combined with amyloid imaging may help elucidate
these unanswered questions.
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Key points
• It is not known how the cognitive phenotype of
DLB is inﬂuenced by hippocampal atrophy or
adjacent medial temporal lobe structures.
• Hippocampal atrophy and medial temporal lobe
cortical thickness were associated with the
severity of cognitive symptoms.
• Atrophy in these structures may partly mediate
speciﬁc cognitive symptoms in DLB.
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